Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 15 September 2009
Vol. 2, Issue 88, p. pe57
Endocannabinoids Can Open the Pain Gate
MacDonald J. Christie* and
Brain and Mind Research Institute, University of Sydney, Sydney, New South Wales 2006, Australia.
Endocannabinoids produced in the spinal cord can enhance pain by dampening the synapses of inhibitory interneurons that usually prevent the perception of innocuous stimuli as painful. This mechanism promotes pain responsiveness to normally innocuous mechanical stimuli in the skin surrounding a site of injury in both animals and humans subjected to sustained stimulation of pain-sensing nerves. The pain-promoting action of endocannabinoids wanes during the development of chronic pain that is induced by inflammation or nerve injury. This finding may partially explain why, in human trials, cannabinoid drugs have been negative for treatment of most types of acute and postsurgical pain but are effective for some chronic pain states.
Nancy R. Gough (10 November 2009) Sci. Signal.2 (96), ec357.
[DOI: 10.1126/scisignal.296ec357] |Abstract »
Peter R. Stern (11 August 2009) Sci. Signal.2 (83), ec269.
[DOI: 10.1126/scisignal.283ec269] |Abstract »
In Science Magazine
Alejandro J. Pernía-Andrade, Ako Kato, Robert Witschi, Rita Nyilas, István Katona, Tamás F. Freund, Masahiko Watanabe, Jörg Filitz, Wolfgang Koppert, Jürgen Schüttler, Guangchen Ji, Volker Neugebauer, Giovanni Marsicano, Beat Lutz, Horacio Vanegas, and Hanns Ulrich Zeilhofer (7 August 2009) Science325 (5941), 760.
[DOI: 10.1126/science.1171870] |Abstract »|Full Text »|PDF »|Supporting Online Material »